期刊文献+

C-型钠尿肽与血管损伤性疾病 被引量:6

C-type Natriuretic Peptide and Injured Vascular Diseases
下载PDF
导出
摘要 C-型钠尿肽(C-type natriuretic peptide,CNP)作为钠尿肽家系的一员,主要是由血管内皮分泌,CNP与血管平滑肌细胞钠尿肽受体-B(NPR-B)结合,激活颗粒型鸟苷酸环化酶,促进细胞内cGMP水平升高,以旁分泌和/或自分泌方式调节循环系统功能稳态。CNP广泛分布于血管系统,尤其在内皮细胞中高表达。CNP具有利钠、利尿、调节血管张力、抑制血管平滑肌细胞迁移、增殖等作用,与高血压、动脉粥样硬化、血栓形成、冠脉成形术后再狭窄和血管钙化等多种血管损伤性疾病密切相关。 C-type natriuretic peptide (CNP) is a member of Natriuretic peptides family which is synthesized and secreted by vascular endothelial ceils. CNP can bind with specific G-protein coupling receptor - natriuretic peptide receptor-B (NPR-B) and elevate cellular cGMP level by activating guanylate cyclase. CNP regulates homeostasis of circulating system in an autocrine/paracrine manner. Vascular system, especially endothelium, is rich in CNP and its receptor. CNP exerts natruretic and natriuretic effect and regulates vessel tone, inhibits migration and proliferation of vascular smooth muscle cell. CNP is tightly correlated with injured vascular diseases such as hypertension, atherosclerosis, thrombogenesis, restenosis and vascular calcification.
出处 《生理科学进展》 CAS CSCD 北大核心 2008年第2期119-123,共5页 Progress in Physiological Sciences
基金 教育部新世纪优秀人才基金(NCET-05-0016) 国家自然科学基金(30470693,30570766)资助课题
关键词 钠尿肽 血管损伤性疾病 血管钙化 natriuretic peptide injured vascular disease vascular calcification
  • 相关文献

参考文献1

二级参考文献10

  • 1Qian JY, Haruno A, Asada Y, et al. Local expression of Ctype natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arter
  • 2Yasuda S, Kanna M, Sakuragi S, et al. Local delivery of single low-dose of C-type natriuretic peptide, an endogenous vascular modulator, inhibits neointimal hyperplasia in a balloon-injured rabbit iliac artery model[J]. J Cardiovasc Pharmacol, 2002,39(6)
  • 3Poulsen H, Olofsson P, Stijernquist M. Effectsof head-down tilt on atrial natriuretic peptide and the rennin system in pregnancy[J]. Hypertension, 1995, 25(6):1161-1165.
  • 4Kishimoto I, Saito Y, Li Y, et al. Cross-talk between the natriuretic peptide system and the angiotensin system[J]. Nippon Rinsho, 2002,60(10) :1923-1928.
  • 5Chen HH, Burnett JC. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system[J]. J Cardiovasc Pharmacol, 1998, 32(3): 22-28.
  • 6Amin J, Carretero OA, Ito S. Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide[J]. Hypertension, 1996,27(3 Pt 2):684-687.
  • 7Honing ML, Smits P, Morrison PJ, et al. C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels[J]. Hypertension, 2001, 37(4): 1179-1183.
  • 8Brunner F, Wolkart G. Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature [J]. Cardiovasc Res, 2001, 51(3) :577-584.
  • 9Wennberg PW, iller VM, Rabelink T,et al. Further attenuation of endothelium dependent relaxation imparted by natriuretic peptide receptor antagonism[J]. Am J Physiol, 1999, 277(4 Pt 2): 1618-1621.
  • 10杨瑛,杨梦庚,姚元庆,姜峰.心房尿钠肽与硫酸镁对妊娠高血压综合征患者的心功能效应[J].心脏杂志,2000,12(6):458-460. 被引量:1

共引文献2

同被引文献38

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部